Exact Sciences
EXAS
#1184
Rank
โ‚น1.748 T
Marketcap
โ‚น9,214
Share price
0.32%
Change (1 day)
82.71%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Market capitalization of Exact Sciences (EXAS)

Market cap: โ‚น1.748 Trillion

As of January 2026 Exact Sciences has a market cap of โ‚น1.748 Trillion. This makes Exact Sciences the world's 1184th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exact Sciences from 2001 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น1.748 T1.05%
2025โ‚น1.730 T89.36%
2024โ‚น913.72 B-17.96%
2023โ‚น1.113 T53%
2022โ‚น727.96 B-27.64%
2021โ‚น1.006 T-30.97%
2020โ‚น1.457 T49.71%
2019โ‚น973.56 B79.12%
2018โ‚น543.53 B35.32%
2017โ‚น401.66 B308.1%
2016โ‚น98.42 B65.98%
2015โ‚น59.29 B-61.53%
2014โ‚น154.12 B198.75%
2013โ‚น51.59 B39.22%
2012โ‚น37.05 B62.99%
2011โ‚น22.73 B62.66%
2010โ‚น13.97 B150.16%
2009โ‚น5.58 B648.51%
2008โ‚น0.74 B-78.23%
2007โ‚น3.42 B2.18%
2006โ‚น3.35 B27.66%
2005โ‚น2.62 B-39.7%
2004โ‚น4.35 B-50.99%
2003โ‚น8.89 B-10.18%
2002โ‚น9.90 B6.76%
2001โ‚น9.27 B

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of Exact Sciences was reported to be:

โ‚น1.745 Trillion
by Nasdaq info icon info icon
โ‚น1.748 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Myriad Genetics
MYGN
โ‚น55.34 B-96.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
โ‚น86.18 B-95.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
โ‚น299.72 B-82.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
โ‚น0.10 B-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น10.718 T 513.04%๐Ÿ‡ซ๐Ÿ‡ท France